// Your mission Eligo is building a pioneering platform technology that enables us to engineer phage-derived particles (Eligobiotics) to package and deliver modular therapeutic DNA payloads to genetically (re)program a wide range of bacterial species in
Alaya.bio is a preclinical-stage biotech company pioneering a new generation of lentiviral-vector-based polymeric nanoparticles applied to the rapid and universal in situ manufacturing of CAR T-cells. Founded in July 2022 and based in Paris and New